TrialPloS one2015

Midregional Proadrenomedullin Improves Risk Stratification beyond Surgical Risk Scores in Patients Undergoing Transcatheter Aortic Valve Replacement.

Adam Csordas et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.